WebDesidustat. Desidustat ( INN, also known as ZYAN1) is a drug for the treatment of anemia of chronic kidney disease. This drug with the brand name Oxemia is discovered and developed by Zydus Life Sciences. [1] Desidustat reduces the requirement of recombinant erythropoietin requirement in anemia, and decreases EPO-resistance, by reducing IL-6 ... WebDec 27, 2024 · The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) on Monday also recommended granting permission to manufacture and market anti-Covid pill ...
Home EXECUTIVE SECURITY CONFERENCE, LLC
WebOUR MISSION. The Executive Security Conference partners have created CISO XC to bring together Cyber Security Executives and their strategic partners to improve … WebMinutes of the Meeting of Subject Expert Committee (SEC) - Vaccine to review proposals and advice Drugs Controller General (India) in matters for Biologicals & PAC proposals … sycamore square apartments okc
CDSCO panel approves Reliance Life Science
WebRegulatory Process: CDSCO. Based on the molecule, type of the application will be decided (Subsequent New Drug or Global Clinical Trial) Application will be reviewed by drug inspector in first 4 week and prepare summary for expert review. Subject Expert Committee (SEC) meeting. Changes in the Regulatory Process since 2013 has resulted in ... WebJun 21, 2024 · It is further alleged that middleman Dua met Reddy at CDSCO office on June 15 in connection with the approval of the third file of Biocon Biologics. The FIR alleged … WebApr 9, 2024 · At the recent SEC meeting for Analgesic and Rheumatology held on 15th March 2024, the expert panel reviewed the proposal to conduct the Phase III clinical trial titled “A prospective, multicenter, randomized, double-blind, two-arm, parallel-group, active control, comparative clinical study to evaluate the efficacy and safety of R-TPR-055 … texturspray test